Article Details
Retrieved on: 2018-02-14 22:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Baupost Group</b> Llc/Ma owns $2.05 million in Orexigen Therapeutics, Inc., which represents roughly 15.41% of the company's market cap and approximately 40.98% of the institutional ownership. Similar statistics are true for the second largest owner, Bvf Inc/Il, which owns 734,976 shares of the stock are ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here